Was betrifft es? Warum ist das wichtig?

Researchers have an ethical obligation to make their study results public, whether they are positive, negative or inconclusive. By registering study results, the SP-INV fulfils scientific, ethical, and regulatory obligations.

 

As a minimum, study results should be published in a registry recognized by the World Health Organization (WHO) (e.g. ClinicalTrials.gov), on the federal (HumRes) website, and where else the study was initially registered.

 

A study registry has many advantages as it:

  • Functions as a public record where study results are presented in a standardized format
  • Complies with required ethical obligations towards study participants
  • Ensures that research results contribute to overall medical knowledge
  • Reduces publication and outcome reporting biases
  • Facilitates systematic reviews and other research literature reviews

Was muss ich befolgen?

As SP-INV:

  • Update any selected internationally recognised public registries
  • Grant data access to all those who may benefit from your study results (e.g. with or without proven benefit). This is important to further medical research
  • Consider informing study participants and/or their community about your study results

 

Once the Ethics Committee (EC) has approved your BASEC submitted study, all required study information is automatically updated in the FOPH HumRes registry.

 

Scientific publications:

  • Make an attempt to publish your research in a scientific peer-reviewed journal, as it will make findings more easily available to the scientific community
  • Include experts able to support you with the write-up of a scientific publication (e.g. statistician, medical reviewer)
  • Adhere to publication agreements defined at study start (e.g. selection of publication partner(s), contribution and authorship, scientific journal publication guidelines)

 

Irrespective of publication means and source, implement robust measures to ensure that the confidentiality of study participants is protected at all times.

Wo kann ich Hilfe anfordern?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

External Links

Swissethics – see in particular

  • BASEC The Business Administration System for the Ethics Committee
  • RAPS Registry, a database of all projects approved by the ethics committees in Switzerland

Swiss and international registries:

References

Declaration of Helsinki – see in particular principle

  • 36 Registration, Publication, and Dissemination of Results

SAMS Research with human subjects – see in particular chapter

  • Chapter 11 Publication of study results

CIOMS guideline – see in particular

  • 24 Public accountability for health-related research

ICMJE – see in particular

  • Clinical trials recommendation

Swiss Law

HRA – see in particular article

  • Art. 56 Registration

ClinO – see in particular articles

  • Art. 64 - 67 Registration and publication

ClinO-MD – see in particular articles

  • Art. 41 Registration
  • Art. 42 Publication of results
Abkürzungen
  • BASEC – Business Administration System for Ethics Committees
  • CIOMS – Council for International. Organizations of Medical Sciences
  • ClinO – Clinical Trials Ordinance
  • ClinO-MD – Ordinance on Clinical Trials with Medical Devices
  • CTU – Clinical Trials Unit
  • EC – Ethics Committee
  • EudraCT – European Union Drug Regulating Authorities Clinical Trials Database
  • CTU – Clinical Trials Unit
  • FOPH – Federal Office of Public Health
  • HRA – Human Research Act
  • HumRes – Human Research in Switzerland
  • ICMJE – International Committee of Medical Journal Editors
  • RAPS – Registry of all Projects in Switzerland
  • SAMS – Swiss Academy of Medical Sciences
  • SP-INV – Sponsor Investigator
  • RA – Regulatory Authorities
  • WHO – World Health Organization
Completion ↦ Ethics and Laws ↦ Publications ↦ Responsibilities
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Completion ↦ Ethics and Laws ↦ Publications ↦ Responsibilities